Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)
Clinical trial NCT01187303 · COMPLETED
Trial details
- NCT number
- NCT01187303
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.